300 related articles for article (PubMed ID: 22019461)
1. Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver.
Díaz ME; González L; Miquet JG; Martínez CS; Sotelo AI; Bartke A; Turyn D
Cell Signal; 2012 Feb; 24(2):514-523. PubMed ID: 22019461
[TBL] [Abstract][Full Text] [Related]
2. GH modulates hepatic epidermal growth factor signaling in the mouse.
González L; Díaz ME; Miquet JG; Sotelo AI; Fernández D; Dominici FP; Bartke A; Turyn D
J Endocrinol; 2010 Mar; 204(3):299-309. PubMed ID: 20032199
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of epidermal growth factor (EGF) signaling by growth hormone (GH).
González L; Miquet JG; Irene PE; Díaz ME; Rossi SP; Sotelo AI; Frungieri MB; Hill CM; Bartke A; Turyn D
J Endocrinol; 2017 May; 233(2):175-186. PubMed ID: 28223314
[TBL] [Abstract][Full Text] [Related]
4. Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2.
Zhang SQ; Tsiaras WG; Araki T; Wen G; Minichiello L; Klein R; Neel BG
Mol Cell Biol; 2002 Jun; 22(12):4062-72. PubMed ID: 12024020
[TBL] [Abstract][Full Text] [Related]
5. Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy.
Surviladze Z; Sterk RT; DeHaro SA; Ozbun MA
J Virol; 2013 Mar; 87(5):2508-17. PubMed ID: 23255786
[TBL] [Abstract][Full Text] [Related]
6. Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signaling.
Edouard T; Combier JP; Nédélec A; Bel-Vialar S; Métrich M; Conte-Auriol F; Lyonnet S; Parfait B; Tauber M; Salles JP; Lezoualc'h F; Yart A; Raynal P
Mol Cell Biol; 2010 May; 30(10):2498-507. PubMed ID: 20308328
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2.
Haider UG; Roos TU; Kontaridis MI; Neel BG; Sorescu D; Griendling KK; Vollmar AM; Dirsch VM
Mol Pharmacol; 2005 Jul; 68(1):41-8. PubMed ID: 15849355
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
9. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
Holgado-Madruga M; Wong AJ
Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
[TBL] [Abstract][Full Text] [Related]
10. Ames dwarf (Prop1(df)/Prop1(df)) mice display increased sensitivity of the major GH-signaling pathways in liver and skeletal muscle.
Miquet JG; Muñoz MC; Giani JF; González L; Dominici FP; Bartke A; Turyn D; Sotelo AI
Growth Horm IGF Res; 2010 Apr; 20(2):118-26. PubMed ID: 20022531
[TBL] [Abstract][Full Text] [Related]
11. The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway.
Mattoon DR; Lamothe B; Lax I; Schlessinger J
BMC Biol; 2004 Nov; 2():24. PubMed ID: 15550174
[TBL] [Abstract][Full Text] [Related]
12. A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor.
Yart A; Laffargue M; Mayeux P; Chretien S; Peres C; Tonks N; Roche S; Payrastre B; Chap H; Raynal P
J Biol Chem; 2001 Mar; 276(12):8856-64. PubMed ID: 11134009
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.
Miquet JG; Freund T; Martinez CS; González L; Díaz ME; Micucci GP; Zotta E; Boparai RK; Bartke A; Turyn D; Sotelo AI
Cell Cycle; 2013 Apr; 12(7):1042-57. PubMed ID: 23428905
[TBL] [Abstract][Full Text] [Related]
14. Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice.
Kilic U; Caglayan AB; Beker MC; Gunal MY; Caglayan B; Yalcin E; Kelestemur T; Gundogdu RZ; Yulug B; Yılmaz B; Kerman BE; Kilic E
Redox Biol; 2017 Aug; 12():657-665. PubMed ID: 28395173
[TBL] [Abstract][Full Text] [Related]
15. ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.
Yu CF; Liu ZX; Cantley LG
J Biol Chem; 2002 May; 277(22):19382-8. PubMed ID: 11896055
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
17. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway.
Cao C; Huang X; Han Y; Wan Y; Birnbaumer L; Feng GS; Marshall J; Jiang M; Chu WM
Sci Signal; 2009 Apr; 2(68):ra17. PubMed ID: 19401591
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
19. Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer.
Hernandez-Aya LF; Gonzalez-Angulo AM
Oncologist; 2011; 16(4):404-14. PubMed ID: 21406469
[TBL] [Abstract][Full Text] [Related]
20. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
